Evaxion Biotech

    OverviewSuggest Edit

    Evaxion Biotech is a company focused on the development of vaccines against cancer and infectious diseases. It discovers antigens and neo-epitopes for vaccines and antibodies using artificial intelligence. The company provides PIONEER and EDEN platforms that predict, rank, and optimize epitopes and antigens that elicit an immune response against cancers and infectious diseases.
    TypePrivate
    Founded2008
    Websiteevaxion-biotech.com

    Latest Updates

    Employees (est.) (Mar 2020)43

    Evaxion Biotech Financials and Metrics

    Summary Metrics

    Founding Date

    2008
    Show all financial metrics

    Evaxion Biotech Online and Social Media Presence

    Embed Graph

    Evaxion Biotech Frequently Asked Questions

    • When was Evaxion Biotech founded?

      Evaxion Biotech was founded in 2008.

    • How many employees does Evaxion Biotech have?

      Evaxion Biotech has 43 employees.

    • Who are Evaxion Biotech competitors?

      Competitors of Evaxion Biotech include Remedy Plan, Aeglea Biotherapeutics and Immune Design.